A retrospective analysis of ibrutinib outcomes in relapsed or refractory mantle cell lymphoma
CONCLUSION: This study underscores the importance of considering patient characteristics before administering ibrutinib as salvage therapy. Early relapse was associated with poor outcomes, highlighting the need for novel therapeutic strategies.PMID:38151961 | DOI:10.5045/br.2023.2023208 (Source: Blood Research)
Source: Blood Research - December 28, 2023 Category: Hematology Authors: Yong-Pyo Lee Ye Ji Jung Junhun Cho Young Hyeh Ko Won Seog Kim Seok Jin Kim Sang Eun Yoon Source Type: research
Lenalidomide as a treatment for patients with AL amyloidosis and cardiac involvement
Blood Res. 2023 Dec 31;58(4):242-245. doi: 10.5045/br.2023.2023194.NO ABSTRACTPMID:38151962 | DOI:10.5045/br.2023.2023194 (Source: Blood Research)
Source: Blood Research - December 28, 2023 Category: Hematology Authors: Seo Yoon Jang Ja Min Byun Sung-Soo Yoon Jin Chul Paeng Seung-Pyo Lee Youngil Koh Source Type: research
Correlation between red blood cell distribution width/platelet count and prognosis of newly diagnosed diffuse large B-cell lymphoma
CONCLUSION: A high RPR (≥0.0549) in patients with newly diagnosed DLBCL is an independent risk factor for a poor prognosis.PMID:38031470 | DOI:10.5045/br.2023.2023156 (Source: Blood Research)
Source: Blood Research - November 30, 2023 Category: Hematology Authors: Xiaobo Liu Yanliang Bai Ying Liu Weiya Li Yabin Cui Jinhui Xu Xingjun Xiao Xiaona Niu Kai Sun Source Type: research
Clinico-pathological features and treatment outcomes of high-grade B cell lymphoma-a tertiary cancer center experience
Blood Res. 2023 Dec 31;58(4):240-242. doi: 10.5045/br.2023.2023169. Epub 2023 Nov 30.NO ABSTRACTPMID:38031471 | DOI:10.5045/br.2023.2023169 (Source: Blood Research)
Source: Blood Research - November 30, 2023 Category: Hematology Authors: Anindya Mukherjee Sujay Rainchwar Aakanksha Singh Rohan Halder Pritish Chandra Patra Rayaz Ahmed Dinesh Bhurani Narendra Agrawal Source Type: research
Successful recovery of poor graft function by administration of romiplostim in a multiple myeloma case with poor graft function following autologous stem cell transplantation
Blood Res. 2023 Dec 31;58(4):237-240. doi: 10.5045/br.2023.2023185. Epub 2023 Nov 30.NO ABSTRACTPMID:38031472 | DOI:10.5045/br.2023.2023185 (Source: Blood Research)
Source: Blood Research - November 30, 2023 Category: Hematology Authors: Jeongmin Yim Sung-Soo Park Jong-Mi Lee Jae-Ho Yoon Hee-Je Kim Chang-Ki Min Source Type: research
A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study
CONCLUSION: The treatment outcomes of patients with relapsed or refractory CD30-positive lymphoma improved with BV treatment, and the safety profile was manageable.PMID:38031473 | DOI:10.5045/br.2023.2023206 (Source: Blood Research)
Source: Blood Research - November 30, 2023 Category: Hematology Authors: Seok Jin Kim Young Rok Do Ho-Sup Lee Won-Sik Lee Jee Hyun Kong Jae-Yong Kwak Hyeon-Seok Eom Joon Ho Moon Jun Ho Yi Jeong-Ok Lee Jae-Cheol Jo Deok-Hwan Yang Source Type: research
Correlation between red blood cell distribution width/platelet count and prognosis of newly diagnosed diffuse large B-cell lymphoma
CONCLUSION: : A high RPR (≥0.0549) in patients with newly diagnosed DLBCL is an independent risk factor for a poor prognosis.PMID:38031470 | DOI:10.5045/br.2023.2023156 (Source: Blood Research)
Source: Blood Research - November 30, 2023 Category: Hematology Authors: Xiaobo Liu Yanliang Bai Ying Liu Weiya Li Yabin Cui Jinhui Xu Xingjun Xiao XiaoNa Niu Kai Sun Source Type: research
Clinico-pathological features and treatment outcomes of high-grade B cell lymphoma- a tertiary cancer center experience
Blood Res. 2023 Nov 30. doi: 10.5045/br.2023.2023169. Online ahead of print.NO ABSTRACTPMID:38031471 | DOI:10.5045/br.2023.2023169 (Source: Blood Research)
Source: Blood Research - November 30, 2023 Category: Hematology Authors: Anindya Mukherjee Sujay Rainchwar Aakanksha Singh Rohan Halder Pritish Chandra Patra Rayaz Ahmed Dinesh Bhurani Narendra Agrawal Source Type: research
Successful recovery of poor graft function by administration of romiplostim in a multiple myeloma case with poor graft function following autologous stem cell transplantation
Blood Res. 2023 Nov 30. doi: 10.5045/br.2023.2023185. Online ahead of print.NO ABSTRACTPMID:38031472 | DOI:10.5045/br.2023.2023185 (Source: Blood Research)
Source: Blood Research - November 30, 2023 Category: Hematology Authors: Jeongmin Yim Sung-Soo Park Jong-Mi Lee Jae-Ho Yoon Hee-Je Kim Chang-Ki Min Source Type: research
A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study
CONCLUSION: s : The treatment outcomes of patients with relapsed or refractory CD30-positive lymphoma improved with BV treatment, and the safety profile was manageable.PMID:38031473 | DOI:10.5045/br.2023.2023206 (Source: Blood Research)
Source: Blood Research - November 30, 2023 Category: Hematology Authors: Seok Jin Kim Young Rok Do Ho-Sup Lee Won-Sik Lee Jee Hyun Kong Jae-Yong Kwak Hyeon-Seok Eom Joon Ho Moon Jun Ho Yi Jeong-Ok Lee Jae-Cheol Jo Deok-Hwan Yang Source Type: research
Correlation between red blood cell distribution width/platelet count and prognosis of newly diagnosed diffuse large B-cell lymphoma
CONCLUSION: : A high RPR (≥0.0549) in patients with newly diagnosed DLBCL is an independent risk factor for a poor prognosis.PMID:38031470 | DOI:10.5045/br.2023.2023156 (Source: Blood Research)
Source: Blood Research - November 30, 2023 Category: Hematology Authors: Xiaobo Liu Yanliang Bai Ying Liu Weiya Li Yabin Cui Jinhui Xu Xingjun Xiao XiaoNa Niu Kai Sun Source Type: research
Clinico-pathological features and treatment outcomes of high-grade B cell lymphoma- a tertiary cancer center experience
Blood Res. 2023 Nov 30. doi: 10.5045/br.2023.2023169. Online ahead of print.NO ABSTRACTPMID:38031471 | DOI:10.5045/br.2023.2023169 (Source: Blood Research)
Source: Blood Research - November 30, 2023 Category: Hematology Authors: Anindya Mukherjee Sujay Rainchwar Aakanksha Singh Rohan Halder Pritish Chandra Patra Rayaz Ahmed Dinesh Bhurani Narendra Agrawal Source Type: research
Successful recovery of poor graft function by administration of romiplostim in a multiple myeloma case with poor graft function following autologous stem cell transplantation
Blood Res. 2023 Nov 30. doi: 10.5045/br.2023.2023185. Online ahead of print.NO ABSTRACTPMID:38031472 | DOI:10.5045/br.2023.2023185 (Source: Blood Research)
Source: Blood Research - November 30, 2023 Category: Hematology Authors: Jeongmin Yim Sung-Soo Park Jong-Mi Lee Jae-Ho Yoon Hee-Je Kim Chang-Ki Min Source Type: research
A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study
CONCLUSION: s : The treatment outcomes of patients with relapsed or refractory CD30-positive lymphoma improved with BV treatment, and the safety profile was manageable.PMID:38031473 | DOI:10.5045/br.2023.2023206 (Source: Blood Research)
Source: Blood Research - November 30, 2023 Category: Hematology Authors: Seok Jin Kim Young Rok Do Ho-Sup Lee Won-Sik Lee Jee Hyun Kong Jae-Yong Kwak Hyeon-Seok Eom Joon Ho Moon Jun Ho Yi Jeong-Ok Lee Jae-Cheol Jo Deok-Hwan Yang Source Type: research
Correlation between red blood cell distribution width/platelet count and prognosis of newly diagnosed diffuse large B-cell lymphoma
CONCLUSION: : A high RPR (≥0.0549) in patients with newly diagnosed DLBCL is an independent risk factor for a poor prognosis.PMID:38031470 | DOI:10.5045/br.2023.2023156 (Source: Blood Research)
Source: Blood Research - November 30, 2023 Category: Hematology Authors: Xiaobo Liu Yanliang Bai Ying Liu Weiya Li Yabin Cui Jinhui Xu Xingjun Xiao XiaoNa Niu Kai Sun Source Type: research
